SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
Pursuant to Rule 13a-16 or 15d-16 of
the Securities Exchange Act of 1934
For the Month of April 2005
BioProgress PLC
(Translation of registrant’s name into English)
Hostmoor Avenue
March, Cambridgeshire
United Kingdom. PE15 0AX
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.
Form 20-F þ Form 40-F ¨
Indicate by check mark whether registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
Yes ¨ No þ
If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b):N/A
BioProgress PLC
Form 6-K for the month of April, 2005.
Contents:
Enclosure 1. Press release re: Holdings in the Company.
BioProgress PLC
19 April 2005
SCHEDULE 10
NOTIFICATION OF MAJOR INTERESTS IN SHARES
Bioprogress plc
| 2. | Name of shareholder having a major interest |
Fidelity International Limited
| 3. | Please state whether notification indicates that it is in respect of holding of the shareholder named in 2 above or in respect of a non-beneficial interest or in the case of an individual holder if it is a holding of that person’s spouse or children under the age of 18. |
As above
| 4. | Name of the registered holder(s) and, if more than one holder, the number of shares held by each of them |
132,592 Brown Brothers Harriman Lux
3,617,408 Mellon Bank N.A.
| 5. | Number of shares/amount of stock acquired |
Not disclosed
| 6. | Percentage of issued class |
Not disclosed
| 7. | Number of shares/amount of stock disposed |
Not disclosed
| 8. | Percentage of issued class |
Not disclosed
Ordinary shares of 1p each
Not disclosed
19 April 2005
| 12. | Total holding following this notification |
3,750,000
| 13. | Total percentage holding of issued class following this notification |
3.18%
| 14. | Any additional information |
| 15. | Name of contact and telephone number for queries |
Elizabeth Edwards, 01354 655674
| 16. | Name and signature of authorised company official responsible for making this notification. |
Elizabeth Edwards, Company Secretary
Date of notification: 19 April 2005
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| | |
| | | BIOPROGRESS PLC |
| |
| | | /s/ ELIZABETH EDWARDS
|
| Dated: April 22, 2005 | | Elizabeth Edwards |
| | | Chief Financial Officer |
